Investor AB backs merger between Astra and Zeneca

Investor AB backs merger between Astra and Zeneca Investor AB fully supports the proposal for a merger between Astra and Zeneca. With 10.2 percent of the share capital and 12.1 percent of the voting rights, Investor is Astra´s largest owner when it comes to capital as well as votes. "Our intention is to be an active and lead shareholder also in the new Astra Zeneca. The merger is industrially right for Astra and, thus, also for Investor. Personally, I am convinced that a merged company will have better conditions for positive future development, which is all to the benefit of our shareholders" says Claes Dahlbäck, president and chief executive of Investor. Bo Berggren, chairman of Astra and deputy chairman of Investor, made the following comment: "In the pharmaceutical industry today, large units are required in order to be able to invest reasonably in research and development, which is important for both Astra and Sweden. Hence, I too am fully convinced that this is a good solution for the future". INVESTOR AB For further information: Nils Ingvar Lundin, Managing Director Corporate Relations, +46-8 614 20 49, +46-70 514 20 49 Per Spångberg, Vice President Investor Relations, +46-8 614 20 31, +46-70 624 20 31 ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1998/12/09/19981209BIT00060/bit0001.doc http://www.bit.se/bitonline/1998/12/09/19981209BIT00060/bit0002.pdf

About Us

Investor is the leading owner of Nordic-based international companies, founded by the Wallenberg family a hundred years ago. We own significant minority or majority interests in high quality companies. Through our participation on the boards of directors, we work for continuous improvement of the performance of the companies. With our industrial experience, network and financial strength we strive to make our companies best-in-class. Our cash flow allows us to support strategic initiatives in our companies, capture investment opportunities and provide our shareholders with a dividend. Our Core Investments include listed holdings Atlas Copco, SEB, ABB, Ericsson and the operating subsidiary Mölnlycke Health Care.

Subscribe